S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
S&P 500   4,769.83
DOW   37,689.54
QQQ   409.52
US Navy helicopters fire at Yemen's Houthi rebels and kill several in latest Red Sea shipping attack
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
A lithium-ion battery fire in a cargo ship's hold is out after several days of burning
Chief Justice Roberts casts a wary eye on the uses of artificial intelligence in the federal courts
New Year's Sale: Get MarketBeat All Access Free For 30 Days (Ad)
NASDAQ:IMNN

Imunon (IMNN) Stock Price, News & Analysis

$0.68
+0.02 (+3.03%)
(As of 12/29/2023 ET)
Today's Range
$0.63
$0.72
50-Day Range
$0.66
$1.10
52-Week Range
$0.63
$1.72
Volume
199,877 shs
Average Volume
63,396 shs
Market Capitalization
$6.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00

Imunon MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,664.7% Upside
$12.00 Price Target
Short Interest
Healthy
0.15% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.29mentions of Imunon in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.23) to ($1.95) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.10 out of 5 stars


IMNN stock logo

About Imunon Stock (NASDAQ:IMNN)

Imunon, Inc., a clinical stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The Company's lead clinical programs comprise IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development; and ThermoDox for the treatment of hepatocellular carcinoma. It also has two platform technologies, such as TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies; and PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is based in Lawrenceville, New Jersey.

IMNN Stock Price History

IMNN Stock News Headlines

Imunon (NASDAQ:IMNN) Stock Price Down 3.4%
FINAL OFFER: $9 for a FULL YEAR of stock picks
We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $9. That's less than a cup of coffee! And what do you get for that $9?
FINAL OFFER: $9 for a FULL YEAR of stock picks
We're offering you the chance to subscribe to Behind the Markets for an ENTIRE YEAR for just $9. That's less than a cup of coffee! And what do you get for that $9?
Imunon GAAP EPS of -$0.37 beats by $0.29
Imunon: Q3 Earnings Insights
Imunon Q3 Earnings Preview
Imunon's Earnings Outlook
IMNN: R&D Day Highlights Company Pipeline…
Imunon Inc.
See More Headlines
Receive IMNN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Imunon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/14/2023
Today
12/31/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
4/04/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IMNN
Employees
31
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.00
High Stock Price Target
$12.00
Low Stock Price Target
$12.00
Potential Upside/Downside
+1,664.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-35,900,000.00
Pretax Margin
-23,541.60%

Debt

Sales & Book Value

Annual Sales
$125,000.00
Book Value
$4.13 per share

Miscellaneous

Free Float
9,038,000
Market Cap
$6.39 million
Optionable
Not Optionable
Beta
1.95
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Michael H. Tardugno (Age 72)
    Executive Chairman
    Comp: $1.58M
  • Dr. Corinne M. Le Goff M.B.A. (Age 58)
    Pharm.D., CEO, President & Director
    Comp: $477.73k
  • Dr. Khursheed Anwer M.B.A. (Age 63)
    Ph.D., Executive VP & Chief Scientific Officer
    Comp: $540.87k
  • Mr. Timothy J. Tumminello CPA (Age 65)
    Chief Accounting Officer & Controller
    Comp: $108.31k
  • Ms. Marianne M. Lambertson
    Vice President of Communications & Investor Relations
  • Dr. Sebastien Hazard M.D.
    Executive VP & Chief Medical Officer














IMNN Stock Analysis - Frequently Asked Questions

Should I buy or sell Imunon stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Imunon in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" IMNN shares.
View IMNN analyst ratings
or view top-rated stocks.

What is Imunon's stock price target for 2024?

1 Wall Street analysts have issued twelve-month target prices for Imunon's stock. Their IMNN share price targets range from $12.00 to $12.00. On average, they expect the company's share price to reach $12.00 in the next year. This suggests a possible upside of 1,664.7% from the stock's current price.
View analysts price targets for IMNN
or view top-rated stocks among Wall Street analysts.

How have IMNN shares performed in 2023?

Imunon's stock was trading at $1.35 on January 1st, 2023. Since then, IMNN shares have decreased by 49.6% and is now trading at $0.68.
View the best growth stocks for 2023 here
.

When is Imunon's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 4th 2024.
View our IMNN earnings forecast
.

How were Imunon's earnings last quarter?

Imunon, Inc. (NASDAQ:IMNN) posted its earnings results on Tuesday, November, 14th. The company reported ($0.37) EPS for the quarter, beating analysts' consensus estimates of ($0.66) by $0.29.

How do I buy shares of Imunon?

Shares of IMNN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:IMNN) was last updated on 12/31/2023 by MarketBeat.com Staff

My Account -